natgillin/translations-raw huggingface dataset:
The inhaler is white with a semi-transparent wine red mouthpiece cover. 
Inhalator je bijele boje s poluprozirnim poklopcem nastavka za usta koji je boje crvenog vina.
If any of the above applies to you, or if you are not sure, talk to your doctor, pharmacist or nurse before using Budesonide/Formoterol Teva . 
Ako se bilo što od gore navedenog odnosi na Vas ili niste sigurni, prije uporabe lijeka Budezonid/Formoterol
How to store Budesonide/Formoterol Teva (page 21) 6. 
Kako čuvati Budezonid/Formoterol Teva (stranica 21) Sadržaj pakiranja i druge informacije (stranica 22)
Norton (Waterford) Limited T/A Teva Pharmaceuticals Ireland Unit 27/35, IDA Industrial Park, Cork Road, Waterford, Ireland Teva Pharmaceuticals Europe B.V., Swensweg 5, 2031 GA Haarlem, Netherlands Teva Operations Sp. Z o.o ul, Mogilska 80; 31-546 Krakow, Poland. 
Norton (Waterford) Limited T/A Teva Pharmaceuticals Irska Unit 27/35, IDA Industrial Park, Cork Road, Waterford, Irska
Rare side effects: may affect up to 1 in 1,000 people 
Rijetke nuspojave: mogu se javiti kod do 1 na 1000 osoba
• If you are using Budesonide/Formoterol Teva for asthma, your doctor will want to regularly check your symptoms. 
Teva za astmu, Vaš liječnik će tražiti redovitu kontrolu vaših simptoma.
EXP Use the product within 6 months of removing from foil wrapping. 
Rok valjanosti Lijek upotrijebite u roku od 6 mjeseci nakon vađenja iz folije.
Each Budesonide/Formoterol Teva inhaler contains 120 inhalations and has a white body with a semitransparent wine red mouthpiece cover. 
Teva sadrži 120 inhalacija i ima bijelo tijelo s poluprozirnim poklopcem nastavka za usta boje crvenog vina.
Each Budesonide/Formoterol Teva inhaler contains 60 inhalations and has a white body with a semitransparent wine red mouthpiece cover. 
Teva sadrži 60 inhalacija i ima bijelo tijelo s poluprozirnim poklopcem nastavka za usta boje crvenog vina.
Tell your doctor if you have any of the following while taking Budesonide/Formoterol Teva they could be symptoms of a lung infection: 
Teva pojavi bilo koja od sljedećih nuspojava - može se raditi o simptomima infekcije pluća:
A randomised, open-label placebo study was performed in children and adolescents with asthma (aged 6-17 years), adults with asthma (aged 18-45 years), adults with chronic obstructive pulmonary disease (COPDaged >50 years) and healthy volunteers (aged 18-45 years) to evaluate the peak inspiratory flow rate (PIFR) and other related inhalation parameters following inhalation from a Spiromax device (containing placebo) compared with inhalation from an already marketed multi-dose dry powder inhaler device (containing placebo). 
> 50 godina) i zdravim dobrovoljcima (u dobi od 1845 godina) za procjenu brzine vršnog inspiratornog protoka (eng. peak inspiratory flow rate, PIFR) i drugih povezanih inhalacijskih parametara nakon inhalacije iz inhalatora Spiromax (koji sadrži placebo) u usporedbi s inhalacijom iz već na tržištu dostupnog inhalatora s više doza suhog praška (koji sadrži placebo).
How to store Budesonide/Formoterol Teva (page 19) 6. 
Kako čuvati Budezonid/Formoterol Teva (stranica 19) Sadržaj pakiranja i druge informacije (stranica 19)
Once asthma symptoms are controlled, consideration may be given to gradually reducing the dose of Budesonide/Formoterol Teva . 
Kada su simptomi astme kontrolirani, može se razmotriti postupno smanjenje doze lijeka Budezonid/Formoterol Teva.
Budesonide/Formoterol Teva 320 micrograms/9 micrograms inhalation powder budesonide/formoterol fumarate dihydrate 
Budezonid/Formoterol Teva 320 mikrograma/9 mikrograma prašak inhalata budezonid/ formoterolfumarat dihidrat
Budesonide/Formoterol Teva 160 micrograms / 4.5 micrograms inhalation powder 
Teva 160 mikrograma/4,5 mikrograma prašak inhalata
Each delivered dose (the dose that leaves the mouthpiece of the Spiromax) contains 160 micrograms of budesonide and 4.5 micrograms of formoterol fumarate dihydrate. 
Jedna primijenjena doza (doza koja izlazi iz nastavka za usta inhalatora Spiromax) sadrži 160 mikrograma budezonida i 4,5 mikrograma formoterolfumarat dihidrata.
Each delivered dose (the dose that leaves the mouthpiece of the Spiromax) contains 320 micrograms of budesonide and 9 micrograms of formoterol fumarate dihydrate. 
Jedna primijenjena doza (doza koja izlazi iz nastavka za usta inhalatora Spiromax) sadrži 320 mikrograma budezonida i 9 mikrograma formoterol fumarat dihidrata.
Patients should be reassessed regularly by their prescriber/health care provider so that the dose of Budesonide/Formoterol Teva remains optimal. 
Bolesnike mora redovito procijenjivati liječnik koji im propisuje lijekove/pružatelj zdravstvene skrbi kako bi doza inhalatora Budezonid/Formoterol
Each delivered (inhaled) dose contains 160 micrograms of budesonide and 4.5 micrograms of formoterol fumarate dihydrate. 
Jedna primijenjena (inhalirana) doza sadrži 160 mikrograma budezonida i 4,5 mikrograma formoterolfumarat dihidrata.
Once asthma symptoms are controlled, consideration may be given to gradually reducing the dose of Budesonide/Formoterol Teva. 
Nakon što se postigne kontrola simptoma astme, može se razmotriti postupno smanjenje doze lijeka Budezonid/Formoterol Teva.
Each delivered (inhaled) dose contains 320 micrograms of budesonide and 9 micrograms of formoterol fumarate dihydrate. 
Jedna primijenjena (inhalirana) doza sadrži 320 mikrograma budezonida i 9 mikrograma formoterolfumarat dihidrata.
For a fixed-dose combination therapy of budesonide and formoterol fumarate dihydrate or the concomitant treatment with formoterol and budesonide, no clinical data on exposed pregnancies are available. 
Nema dostupnih kliničkih podataka o trudnoćama izloženim terapiji kombinacijom fiksne doze budezonida i formoterolfumarat dihidrata ili istodobnom liječenju formoterolom i budezonidom.
What you need to know before you use Budesonide/Formoterol Teva (page 5) 3. 
Što je Budezonid/Formoterol Teva i za što se koristi (stranica 3) Što morate znati prije nego počnete primjenjivati Budezonid/Formoterol Teva (stranica 5) Kako primjenjivati Budezonid/Formoterol Teva (stranica 8) Moguće nuspojave (stranica 16)
Budesonide/Formoterol Teva is an inhalation powder. 
Teva je prašak inhalata.
Patients should be reminded to take their Budesonide/Formoterol Teva maintenance dose as prescribed, even when asymptomatic. 
Bolesnike se mora podsjetiti da svoju dozu održavanja lijekom Budezonid/Formoterol
Budesonide/Formoterol Teva is not indicated for use in children, 12 years of age and younger or adolescents, 13 to 17 years of age. 
Budezonid/Formoterol Teva nije indiciran za primjenu u djece, u dobi od 12 godina i mlađe, niti za adolescente u dobi od 13 do 17 godina.
Budesonide/Formoterol Teva 160 micrograms / 4.5 micrograms inhalation powder budesonide/ formoterol fumarate dihydrate 
Teva 160 mikrograma/4,5 mikrograma prašak inhalata budezonid/ formoterolfumarat dihidrat
The most common symptoms that may occur after if you use more Budesonide/Formoterol Teva than you should are trembling, headache or a rapid heartbeat. 
Najčešći simptomi koji se mogu pojaviti ako koristite veću količinu lijeka Budezonid/Formoterol
Budesonide/Formoterol Teva is NOT indicated for use in children 12 years of age and younger or adolescents 13 to 17 years of age. 
Budezonid/Formoterol Teva NIJE indiciran za primjenu u djece s navršenih 12 godina i mlađu niti za adolescente u dobi od 13 do 17 godina.
Budesonide/Formoterol Teva is indicated in adults 18 years of age and older only. 
Teva indiciran je samo u odraslih u dobi od 18 godina i starijih.
Asthma Using Budesonide/Formoterol Teva and a separate ‘reliever inhaler' 
Primjena lijeka Budezonid/Formoterol Teva i zasebnog 'inhalatora za brzo ublažavanje simptoma'
Budesonide/Formoterol Teva 160 mcg/4.5 mcg inhalation powder budesonide/formoterol fumarate dihydrate 
Teva 160 μg/4,5 μg prašak inhalata budezonid/formoterolfumarat dihidrat
Budesonide/Formoterol Teva is taken as regular maintenance treatment with a separate rapid-acting bronchodilator reliever inhaler. 
Teva uzima se kao redovita terapija održavanja s posebnim inhalatorom koji sadrži brzodjelujući bronhodilatator za hitno simptomatsko liječenje.
Adults (18 years and older): 2 inhalations twice a day. 
Odrasli (s 18 godina i stariji): 2 inhalacije dvaput dnevno.
Adults (18 years and older): 1 inhalation twice daily 
Odrasli (s 18 godina i više): 1 inhalacija dvaput dnevno
-in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. 
-u bolesnika u kojih astma nije zadovoljavajuće kontrolirana inhalacijskim kortikosteroidima i ″prema potrebi″ inhalacijskim kratkodjelujućim agonistima ß2-adrenergičkih receptora ili -u bolesnika u kojih je astma već zadovoljavajuće kontrolirana primjenom i inhalacijskih kortikosteroida i dugodjelujućih agonista ß2-adrenergičkih receptora.
- in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. 
-u bolesnika u kojih astma nije zadovoljavajuće kontrolirana inhalacijskim kortikosteroidima i „prema potrebi“ inhalacijskim kratkodjelujućim agonistima ß2-adrenergičkih receptora. ili -u bolesnika u kojih astma već zadovoljavajuće kontrolirana primjenom i inhalacijskih kortikosteroida i dugodjelujućim agonistima ß2-adrenergičkih receptora.
What Budesonide/Formoterol Teva looks like and contents of the pack 
Teva izgleda i sadržaj pakiranja
Budesonide/Formoterol Teva 160 micrograms /4.5 micrograms inhalation powder budesonide / formoterol fumarate dihydrate STATEMENT OF ACTIVE SUBSTANCE(S) 
Teva 160 mikrograma/4,5 mikrograma prašak inhalata budezonid / formoterolfumarat dihidrat NAVOĐENJE DJELATNE/IH
If you become wheezy or breathless, or develop any other symptoms of an asthma attack, use your ‘reliever inhaler', then seek medical advice. 
primijenite 'inhalator za brzo ublažavanje simptoma', a zatim zatražite liječnički savjet.
Budesonide/Formoterol Teva is not intended for the initial management of asthma. 
Teva nije namijenjen za početno zbrinjavanje astme.
When used for asthma, your doctor will prescribe Budesonide/Formoterol Teva together with a separate ‘reliever inhaler' such as salbutamol. 
Kada se koristi za astmu, liječnik će Vam propisati Budezonid/Formoterol
Do not use Budesonide/Formoterol Teva just before exercise to stop asthma symptoms from occurring, use your separate ‘reliever inhaler'. 
Teva neposredno prije tjelovježbe kako biste spriječili pojavu simptoma astme, primijenite zasebni „inhalator za brzo ublažavanje simptoma”
If you use more Budesonide/Formoterol Teva than you should, contact your doctor, pharmacist or nurse for advice. 
Teva nego što biste trebali, obratite se za savjet svojem liječniku, ljekarniku ili medicinskoj sestri.
Do not use Budesonide/Formoterol Teva 320/9 micrograms as a ‘reliever inhaler'. 
Teva 320/9 mikrograma kao „inhalator za brzo ublažavanje simptoma“.
Adults (18 years and older): • 1 inhalation twice a day. 
Odrasli (s 18 godina i više) • 1 inhalacija dvaput dnevno.
Adults (18 years and older): 2 inhalations twice daily. 
Odrasli (s 18 godina i više) 2 inhalacije dvaput dnevno.
58, rue du Pont de Créteil 94100 Saint-Maur-Des-Fossés - France 
58, rue du Pont de Créteil 94100 Saint-Maur-Des-Fossés - Francuska
If you are given more X than you should 
Ako primite više X nego što ste trebali
Additionally, there are important individual variations with regards to the onset and duration of action. 
Dodatno, postoje važne individualne razlike s obzirom na nastup i trajanje djelovanja.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you. 
Pažljivo pročitajte cijelu uputu prije nego počnete primati ovaj lijek jer sadrži Vama važne podatke.
To date, no data are available on humans. 
Do danas, podaci u ljudi nisu dostupni.
Serious adverse experiences are generally systemic. 
Ozbiljne nuspojave obično su sistemske.
The higher risk of bleeding is more associated with the procedure, rather than with the medicine. 
Povećan rizik od krvarenja je više povezan s postupkom nego s lijekom.
They will determine the appropriate dose taking into account the procedure, your age, your weight and your general health. 
Oni će odrediti odgovarajuću dozu uzimajući u obzir postupak, Vašu dob, tjelesnu težinu i opće zdravlje.
Limited data of overdose are available. 
Dostupni su ograničeni podaci o predoziranju.
X with food 
X s hranom
No specific carcinogenicity studies were performed. 
Nisu provedena nikakva specifična ispitivanja kancerogenosti.
Frequency “not known”: “not known (cannot be estimated from the available data)”. 
Učestalost “nepoznato”: “nepoznato (ne može se procijeniti na temelju dostupnih podataka)”.
This property could be beneficial when the use of vasoconstrictor is contraindicated. 
Ova svojstva mogu biti korisna kada je uporaba vazokonstriktora kontraindicirana.
The injection rate shall be very slow (1 ml/min). 
Injiciranje mora biti vrlo sporo (1 ml/min).
− low blood pressure; 
− nizak krvni tlak;
However, considering the lack of data for mepivacaine, a risk to the newborns/infants cannot be excluded. 
Međutim, zbog nedostatka podataka za mepivakain, ne može se isključiti rizik za novorođenče/dojenče.
It should be carefully swabbed either with 70% ethyl alcohol or with 90% pure isopropyl alcohol for pharmaceutical use. 
Potrebno ju je pažljivo obrisati ili sa 70% etilnim alkoholom ili s 90% čistim izopropilnim alkoholom za farmaceutsku upotrebu.
What you need to know before you use X 
Što morate znati prije nego počnete primati X
This medicine does not require any special storage condition. 
Ovaj lijek ne zahtijeva posebne uvjete čuvanja.
The frequencies classification follows the convention: Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1,000 to <1/100), Rare (≥1/10,000 to <1/1,000) and Very rare (<1/10,000). 
Kategorije učestalosti definirane su kako slijedi: vrlo često (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000) i i vrlo rijetko (<1/10 000).
Do not throw away any medicines via wastewater or household. 
Nikada nemojte nikakve lijekove bacati u otpadne vode ili kućni otpad.
Ask your dentist, doctor or pharmacist how to throw away medicines you no longer use. 
liječnika ili ljekarnika kako baciti lijekove koje više ne koristite.
The product information may be subsequently updated by the Member State competent authorities, in liaison with the reference Member State, as appropriate, in accordance with the procedures laid down in Chapter 4 of Title III of Directive 2001/83/EC. 
Nadležna tijela država članica mogu naknadno ažurirati informacije o lijeku, gdje je prikladno u suradnji s referentnom državom članicom, sukladno postupcima navedenima u Poglavlju 4 Glave III Direktive 2001/83/EZ.
Elderly patients: Dosages should be reduced in elderly patients (due to lack of clinical data). 
Dozu je potrebno smanjiti u starijih bolesnika (zbog nedostatka kliničkih podataka).
− excessive sweating; 
− pretjerano znojenje;
In case of relative overdose, patients generally present symptoms within 1-3 minutes. 
U slučaju relativnog predoziranja, bolesnici obično razviju simptome unutar 1-3 minute.
Metabolites are excreted in the urine with less than 10% of unchanged mepivacaine. 
Metaboliti se izlučuju putem urina s manje od 10% nepromijenjenog mepivakaina.
* Rounded to the nearest half-cartridge 
*Zaokruženo na najbližu polovicu uloška
Should cardiac arrest occur, a successful outcome may require prolonged resuscitative efforts. 
Ukoliko dođe do srčanog zastoja, uspješan ishod može zahtijevati produžene napore pri oživljavanju.
Hypotension (with possible circulatory collapse) 
Rijetko Hipotenzija (s mogućim kolapsom cirkulacije)
The maximum plasma level of mepivacaine is achieved approximately after 30-60 minutes. 
Maksimalna razina mepivakaina u plazmi postiže se otprilike nakon 30-60 minuta.
They may also result from hypersensitivity, idiosyncrasy, or diminished tolerance by patient. 
Također mogu biti posljedica preosjetljivosti, idiosinkrazije ili smanjene tolerancije bolesnika.
In severe cases, respiratory arrest may occur. 
U težim slučajevima, može doći do zastoja disanja.
In the absence of compatibility studies, this medicinal product must not be mixed with any other medicinal products. 
Zbog nedostatka ispitivanja kompatibilnosti, ovaj lijek se ne smije miješati s drugim lijekovima.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, dentist or pharmacist for advice before using this medicine. 
Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svom liječniku, stomatologu ili ljekarniku za savjet prije nego uzmete ovaj lijek.
H2 antihistaminics (cimetidine) 
H2-antihistaminici (cimetidin)
Hyperhidrosis (sweating or perspiration) 
Hiperhidroza (znojenje ili perspiracija)
For more extensive procedures one or more cartridges may be required, without exceeding the maximum recommended dose. 
Za opsežnije postupke može biti potrebno jedan ili više uložaka bez prekoračivanja maksimalne preporučene doze.
Loss of consciousness Coma 
Gubitak svijesti Koma
The ratio of the average plasma levels following one and two cartridges were approximately 50%, evidencing a dose proportionality at these dose levels. 
Omjer prosječnih razina u plazmi nakon jednog i dva uloška iznosi približno 50%, što dokazuje proporcionalnost doza pri tim razinama doza.
What X looks like and contents of the pack 
Kako X izgleda i sadržaj pakiranja
Because of their convulsive actions, all local anaesthetics should be used very cautiously. 
Zbog konvulzivnog učinka, svi lokalni anestetici se trebaju koristiti vrlo oprezno.
The total dose of administered mepivacaine should not exceed the maximum recommended dose. 
Ukupna doza primijenjenog mepivakaina ne smije prekoračiti maksimalnu preporučenu dozu.
As patients possess different body weights, each patient possess a different maximum allowed quantity of mepivacaine that can tolerate. 
Kako bolesnici imaju različitu tjelesnu težinu, svaki bolesnik ima različitu maksimalnu dozvoljenu količinu mepivakaina koju može podnijeti.
However, the absence of blood in the syringe does not guarantee that intravascular injection has been avoided. 
Međutim, odsutnost krvi u štrcaljki ne jamči da je izbjegnuto injiciranje u krvnu žilu.
Caution should be taken in all patients with porphyria, as this medicinal product may trigger porphyria. 
Potreban je oprez u svih bolesnika s porfirijom jer ovaj lijek može uzrokovati porfiriju.
Analgesia duration 
Trajanje analgezije
The bioavailability is 100% at the action site. 
Bioraspoloživost Bioraspoloživost iznosi 100% na mjestu djelovanja.
Maximum recommended dosage: 
Maksimalna preporučena doza:
Higher concentrations are found in highly perfused tissues such as liver, lungs, heart and brain. 
Više koncentracije pronalaze se u visoko prokrvljenim tkivima kao što su jetra, pluća, srce i mozak.
• Hypersensitivity to the active substance (or any local anaesthetics agent of the amide type) or to any of the excipients listed in section 6.1, 
• Preosjetljivost na djelatnu tvar (ili bilo koji lokalni anestetik amidnog tipa) ili neku od pomoćnih tvari navedenih u dijelu 6.1,
Mepivacaine binds to plasmatic proteins up to around 75% and can cross placental barrier by simple diffusion. 
Mepivakain se veže na proteine plazme do oko 75% i može prelaziti placentarnu barijeru jednostavnom difuzijom.
These data originated in post-marketing reports, mostly following nerve blocks in mandible, involving various branches of the trigeminal nerve; 
Ovi podaci proizlaze iz post-marketinških izvješća, uglavnom nakon blokade živaca u mandibuli, koji uključuju razne grane trigeminalnog živca:
− loss of consciousness, fit (convulsion), coma; 
− gubitak svijesti, napadaj (konvulzije), koma;
Box containing 50 cartridges. 
Kutija s 50 uložaka.
Undesirable toxic effects may appear at plasma concentrations upper than 5 mg/l, and convulsions could appear with 10 mg/l or higher. 
Neželjeni toksični učinci mogu nastati pri koncentracijama u plazmi višim od 5 mg/l, a konvulzije se mogu javiti pri koncentraciji od 10 mg/l ili višoj.
Children should be given doses commensurate with age and weight. 
Djeci je potrebno osigurati dozu u skladu s njihovom dobi i težinom.
What X contains 
Što X sadrži
Concomitant use of sedatives to reduce patient anxiety: 
Istodobna primjena sedativa za smanjenje anksioznosti bolesnika:
If signs of acute systemic toxicity appear, injection of the local anaesthetic should be stopped immediately. 
Ukoliko se pojave znakovi akutne sistemske toksičnosti, injiciranje lokalnog anestetika mora se odmah prekinuti.
When a dental peripheral nerve block is performed, mepivacaine effect occurs rapidly (generally within 3 to 5 minutes). 
Kada se izvodi blok zubnog perifernog živca, učinak mepivakaina se javlja brzo (obično unutar 3 do 5
Very rare side effects (may affect up to 1 in 10,000 people): − high blood pressure. 
Vrlo rijetke nuspojave (mogu se javiti u do 1 na 10 000 osoba): − visoki krvni tlak.
The duration of the local anaesthetic is unrelated to the half-life as its action is terminated when the drug is removed from the receptor. 
Trajanje učinka lokalnog anestetika nije povezano s poluvremenom jer njegovo djelovanje prestaje kada se lijek odvoji od receptora.
Whereas in case of absolute overdose, signs of toxicity, depending on the injection site, appear about 20-30 minutes after the injection. 
Dok se u slučaju apsolutnog predoziranja, znakovi toksičnosti, ovisno o mjestu injiciranja, pojave oko 20-30
Mepivacaine must be used safely and effectively under appropriate conditions: The local anaesthetic effects may be reduced when {Scandonest and associated names} is injected into an inflamed or infected area. 
Mepivakain se mora primjenjivati sigurno i učinkovito uz odgovarajuće uvjete: Učinci lokalne anestezije mogu se smanjiti kada se {Scandonest i pridružena imena} injicira u upaljeno ili inficirano područje.
This medicine may have a minor influence on the ability to drive and use machines. 
Ovaj lijek može imati mali utjecaj na sposobnost upravljanja vozilima i rada sa strojevima.
Avoid eating, included chewing-gum, until normal sensation is restored because there is a risk that you may bite your lips, cheeks or tongue, especially in children. 
Izbjegavajte jesti, uključujući i žvakanje žvakaće gume, dok se ne vrati normalan osjet jer postoji rizik da se ugrizete za usne, obraze ili jezik, osobito u djece.
Do not use this medicine if you notice that the solution is not clear and colourless. 
Ovaj lijek se ne smije upotrijebiti ako primijetite da otopina nije bistra i bezbojna.
One or more of the following side effects may occur following administration of X. 
Jedna ili više sljedećih nuspojava mogu se javiti nakon primjene lijeka X.
Elimination can be accelerated by acidifying the urine (See section 4.9). 
Eliminacija se može ubrzati povećanjem kiselosti urina (vidjeti dio 4.9).
As the anaesthetic action progressively develops in the nerve, the threshold for electrical excitability gradually increases, the rate of rise of the action potential declines and impulse conduction slows. 
Kako se učinak anestetika progresivno razvija u živcu, prag električne podražljivosti postupno raste, brzina porasta akcijskog potencijala opada i provođenje impulsa usporava.
In case a reinjection is required, patient should be monitored, to identify any sign of relative overdose. 
U slučaju da je potrebna ponovljena primjena lijeka, bolesnika je potrebno pratiti kako bi se otkrio bilo koji znak relativnog predoziranja.
Conduction disorders (atrioventricular block) 
Poremećaji provođenja (atrioventrikularni blok)
The plasma elimination half-life is 2 hours for adults. 
Poluvrijeme eliminacije mepivakaina iz plazme iznosi 2 sata u odraslih osoba.
Presyncope, syncope; 
Presinkopa, sinkopa;
Hypoxaemia and metabolic acidosis may potentiate the cardiovascular toxicity. 
Hipoksemija i metabolička acidoza mogu potencirati kardiovaskularnu toksičnost.
The cartridges should under no circumstance be dipped into any solution whatsoever. 
Uložak se ni u kom slučaju ne smije umočiti u bilo kakvu otopinu.